ArticleBiomedicines2022

Novel Translational Read-through-Inducing Drugs as a Therapeutic Option for Shwachman-Diamond Syndrome.

Valentino Bezzerri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.